Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.60 |
| ▸ | MMP3 | P08254 | 1/20 | 0.60 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.53 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.53 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL153763 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPK1TAAR1CYP1A2CYP3A4 | |
| Biphenyl SCHEMBL28890607 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPK1TAAR1CYP1A2CYP3A4 | |
| SCHEMBL30108088 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPK1TAAR1CYP1A2CYP3A4 | |
| Biphenyl SCHEMBL2548048 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPK1TAAR1CYP1A2CYP3A4 | |
| Biphenyl SCHEMBL4002609 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPK1TAAR1CYP1A2CYP3A4 | |
| SCHEMBL30629023 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPK1TAAR1CYP1A2CYP3A4 | |
| Biphenyl SCHEMBL29008551 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPK1TAAR1CYP1A2CYP3A4 | |
| Biphenyl SCHEMBL164 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPK1TAAR1CYP1A2CYP3A4 | |
| SCHEMBL29560186 | 1.00 | ALDH1A1 (1.00) | ALDH1A1MAPK1TAAR1CYP1A2CYP3A4 | |
| Biphenyl SCHEMBL10791683 | 0.95 | ALDH1A1 (0.90) | ALDH1A1MAPK1TAAR1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 356 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240243364-A1 | LIQUID ELECTROLYTE FOR LITHIUM SECONDARY BATTERIES | SOLVAY SA (BE) | 2024-07-18 | — | — | US | claimed |
| WO-2024078976-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2024-04-18 | — | — | WO | claimed |
| US-20240106000-A1 | ELECTROLYTE COMPOSITION FOR LITHIUM METAL BATTERIES | SOLVAY SA (BE) | 2024-03-28 | — | — | US | claimed |
| EP-4320669-A1 | LIQUID ELECTROLYTE FOR LITHIUM SECONDARY BATTERIES | Solvay SA (BE) | 2024-02-14 | — | — | EP | claimed |
| CN-117121259-A | Liquid electrolyte for lithium secondary battery | 索尔维公司 | 2023-11-24 | — | — | CN | claimed |
| EP-4264709-A1 | ELECTROLYTE COMPOSITION FOR LITHIUM METAL BATTERIES | Solvay SA (BE) | 2023-10-25 | — | — | EP | claimed |
| WO-2023169844-A1 | LIQUID ELECTROLYTE FOR LITHIUM METAL BATTERIES | SOLVAY SA (BE) | 2023-09-14 | — | — | WO | claimed |
| CN-116583980-A | Electrolyte composition for lithium metal battery | 索尔维公司 | 2023-08-11 | — | — | CN | claimed |
| US-20230238567-A1 | ANODE-LESS LITHIUM ION BATTERY | SOLVAY SA (BE) | 2023-07-27 | — | — | US | claimed |
| WO-2023117634-A1 | LITHIUM SECONDARY BATTERIES | SOLVAY SA (BE) | 2023-06-29 | — | — | WO | claimed |
| CN-105074073-B | Make the sheet material of the method for being coupled and aliging of the CNT in nonwoven sheet and the alignment being consequently formed | 纳幕尔杜邦公司 | 2017-07-11 | — | — | CN | claimed |
| CN-106920935-A | Modified lead accumulator of a kind of π types conjugated oxidation reductive polymerization thing and preparation method thereof | 超威电源有限公司 | 2017-07-04 | — | — | CN | claimed |
| CN-104134779-A | High voltage lithium ion battery positive pole piece and preparation method thereof | HEFEI GUOXUAN HIGH TECH POWER ENERGY CO LTD | 2014-11-05 | — | — | CN | claimed |
| CN-102931353-A | High-responsivity visible blind organic UVB (ultraviolet b) optical detector | UNIV ZHEJIANG | 2013-02-13 | — | — | CN | claimed |
| CN-102604689-A | Washing oil with low crystallization point for washing benzene and preparation method of washing oil | XINYI CHEN | 2012-07-25 | — | — | CN | claimed |
| US-5627255-A | ENGINEERING THERMOPLASTICS TO BE USED IN PLACE OF METALS OR GLASS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1997-05-06 | — | — | US | claimed |
| US-5154831-A | Contacting oily substrate with water insoluble solvent and surfactant, separating phases | ENSR CORPORATION (US) | 1992-10-13 | — | — | US | claimed |
| US-4904760-A | HEAT AND CHEMICAL RESISTANCE LOW DIELECTRIC | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 1990-02-27 | — | — | US | claimed |
| EP-0290860-A2 | Thermosetting resin composition | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1988-11-17 | — | — | EP | claimed |
| US-4048087-A | Crystallizing solution and method of preparation thereof | THE DOW CHEMICAL COMPANY (US) | 1977-09-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230238567-A1 | ANODE-LESS LITHIUM ION BATTERY | HCN2, SLC9A2, HCN4 | ALDH1A1 2194/4885MAPK1 1054/4885TAAR1 1701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.